Embecta Corp. Common Stock (EMBC)

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Embecta Corp. Common Stock (EMBC) is listed on Nasdaq, where it has traded since March 21, 2022.

Listed On
Nasdaq
Listed Since
March 21, 2022
Employees
1,850
Market Cap
$326M

About Embecta Corp. Common Stock

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 312 institutions reported holding EMBC, with 50.3 million shares worth $164.8 million in aggregate. The largest reported holder was Vanguard, with 4.6 million shares worth $15.1 million. Of the 5 largest holders listed below, 1 added shares, 3 reduced their positions and 1 held its position unchanged during the quarter.

InstitutionSharesValueQuarter change
Vanguard4,624,584$15MReduced 2.45%
BlackRock4,599,771$15MReduced 49.82%
Yacktman Asset Management4,315,952$14MAdded 17.54%
Deerfield Management Company,2,534,961$8MUnchanged
Jefferies Financial Group2,355,117$8MReduced

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is EMBC?

Embecta Corp. Common Stock (EMBC) is listed on Nasdaq, where it has traded since March 21, 2022.

Who are the largest institutional holders of EMBC?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of EMBC were Vanguard, BlackRock and Yacktman Asset Management.

How many institutions own EMBC?

312 institutions reported a position in EMBC for the quarter ended June 30, 2026, worth $164.8 million in total.

Did institutions buy or sell EMBC last quarter?

Of the 5 largest reported holders, 1 added shares, 3 reduced their positions and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for EMBC.

Every reported institutional holder, plus insider and congressional trades in EMBC, on SentiSense.